Diurnal
Cardiff Medicentre
Heath Park
Cardiff
CF14 4UJ
United Kingdom
Tel: 44-0-29-2068-2069
Website: http://www.diurnal.co.uk/
About Diurnal
Diurnal is a UK-based specialty pharmaceutical company dedicated to developing high-quality hormone therapeutics to aid lifelong treatment for rare and chronic endocrine conditions, including Congenital Adrenal Hyperplasia, Adrenal Insufficiency, Hypogonadism and Hypothyroidism.The company has a strong, multi-skilled entrepreneurial management team with extensive pharmaceutical product development experience and an affiliated network of world-class clinical experts in the area of endocrinology.
YEAR FOUNDED:
2004
LEADERSHIP:
CEO: Martin Whitaker
CFO: Richard Bungay
CSO: Richard Ross
JOBS:
Please click here for Diurnal job opportunities.
FOLLOW DIURNAL:
Tweets by Diurnal
5 articles about Diurnal
-
Diurnal Ltd., a Neurocrine Biosciences Company, Presents Phase 3 Extension Study Data for Modified-Release Hydrocortisone in Patients with Congenital Adrenal Hyperplasia at ENDO 2023
6/15/2023
Diurnal Ltd., a Neurocrine Biosciences company, announced that it will present new post hoc analyses of Phase 3 extension study data for modified-release hydrocortisone, which is being investigated as a treatment for adults with congenital adrenal hyperplasia, at ENDO 2023 June 15–18 in Chicago.
-
Clinigen And Diurnal Partner For European Managed Access Programme For Infacort And Chronocort
3/16/2017
-
Diurnal Release: Company Partners With Ashfield And Sharp For Outsourced Services
1/25/2017
-
IP Group Plc - Portfolio Company Diurnal Announces £6 Million Funding Round
8/5/2014
-
IP Group Plc – Portfolio Company Diurnal Reports Positive Phase 2 Results
6/23/2014